Active Ingredient: AMIKACIN SULFATE
Proprietary Name: AMIKACIN SULFATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 50MG BASE/ML
Reference Listed Drug: No
Reference Standard: Yes
TE Code:
Application Number: A063313
Product Number: 001
Approval Date: Apr 11, 1994
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
